News

Trump is pushing drug companies to lower their prices, but experts cast doubt on how effective this endeavor will prove.
DelveInsight's Vitiligo Market Insights report includes a comprehensive understanding of current treatment practices, vitiligo emerging ...
Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.
Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.
LONG BEACH, Calif. -- Depletion of a payment assistance program has translated into worse vision outcomes for older patients ...
The market for chronic obstructive pulmonary disease treatment devices is projected to witness substantial growth, fueled by ...
In July, spending on TV ads for prescription drugs reached a low not seen since this time last year. | In July, spending on TV ads for prescription drugs reached a low not seen since this time last ...
The administration wants drugmakers to bring medication prices more closely in line with the Most-Favored Nation pricing approach.
Oral upadacitinib may be a promising treatment option for patients with atopic dermatitis-type chronic hand eczema that is ...
The First Trust Health Care AlphaDEX ETF (FXH) was launched on May 8, 2007, and is a passively managed exchange traded fund ...
Cisco today announced it will host Splunk's annual .conf25 user conference from September 8–11, 2025, at the Thomas Michael ...
AbbVie Inc reported a robust second quarter for 2025, with adjusted earnings per share of $2.97 and net revenues reaching $15 ...